Logo image of 1BA.MI

BOEING CO/THE (1BA.MI) Stock Fundamental Analysis

BIT:1BA - Euronext Milan - US0970231058 - Common Stock - Currency: EUR

197.32  -0.38 (-0.19%)

Fundamental Rating

1

Taking everything into account, 1BA scores 1 out of 10 in our fundamental rating. 1BA was compared to 46 industry peers in the Aerospace & Defense industry. 1BA may be in some trouble as it scores bad on both profitability and health. 1BA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

1BA had negative earnings in the past year.
In the past year 1BA has reported a negative cash flow from operations.
In the past 5 years 1BA always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: 1BA reported negative operating cash flow in multiple years.
1BA.MI Yearly Net Income VS EBIT VS OCF VS FCF1BA.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

Looking at the Return On Assets, with a value of -7.45%, 1BA is doing worse than 86.96% of the companies in the same industry.
Industry RankSector Rank
ROA -7.45%
ROE N/A
ROIC N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1BA.MI Yearly ROA, ROE, ROIC1BA.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for 1BA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1BA.MI Yearly Profit, Operating, Gross Margins1BA.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

1

2. Health

2.1 Basic Checks

1BA does not have a ROIC to compare to the WACC, probably because it is not profitable.
1BA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for 1BA has been increased compared to 5 years ago.
Compared to 1 year ago, 1BA has an improved debt to assets ratio.
1BA.MI Yearly Shares Outstanding1BA.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
1BA.MI Yearly Total Debt VS Total Assets1BA.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

1BA has an Altman-Z score of 1.19. This is a bad value and indicates that 1BA is not financially healthy and even has some risk of bankruptcy.
1BA's Altman-Z score of 1.19 is on the low side compared to the rest of the industry. 1BA is outperformed by 84.78% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.19
ROIC/WACCN/A
WACC9.36%
1BA.MI Yearly LT Debt VS Equity VS FCF1BA.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

A Current Ratio of 1.23 indicates that 1BA should not have too much problems paying its short term obligations.
1BA has a Current ratio (1.23) which is comparable to the rest of the industry.
A Quick Ratio of 0.37 indicates that 1BA may have some problems paying its short term obligations.
1BA has a Quick ratio of 0.37. This is amonst the worse of the industry: 1BA underperforms 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.37
1BA.MI Yearly Current Assets VS Current Liabilites1BA.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

More info and screens

3

3. Growth

3.1 Past

1BA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -247.36%.
Looking at the last year, 1BA shows a decrease in Revenue. The Revenue has decreased by -9.15% in the last year.
The Revenue has been decreasing by -4.74% on average over the past years.
EPS 1Y (TTM)-247.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.64%
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%17.67%

3.2 Future

1BA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.17% yearly.
The Revenue is expected to grow by 14.30% on average over the next years. This is quite good.
EPS Next Y91.1%
EPS Next 2Y47.72%
EPS Next 3Y32.64%
EPS Next 5Y20.17%
Revenue Next Year25.38%
Revenue Next 2Y20.52%
Revenue Next 3Y17.13%
Revenue Next 5Y14.3%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1BA.MI Yearly Revenue VS Estimates1BA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B
1BA.MI Yearly EPS VS Estimates1BA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 -10 -20

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for 1BA. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 61.50, 1BA can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1BA indicates a rather expensive valuation: 1BA more expensive than 80.43% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of 1BA to the average of the S&P500 Index (36.42), we can say 1BA is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 61.5
1BA.MI Price Earnings VS Forward Price Earnings1BA.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1BA.MI Per share data1BA.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as 1BA's earnings are expected to grow with 32.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.72%
EPS Next 3Y32.64%

More info and screens

0

5. Dividend

5.1 Amount

1BA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOEING CO/THE

BIT:1BA (7/30/2025, 7:00:00 PM)

197.32

-0.38 (-0.19%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)04-23 2025-04-23/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners74.46%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap148.78B
Analysts82.78
Price Target209.04 (5.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.94%
Min EPS beat(2)-91.07%
Max EPS beat(2)63.2%
EPS beat(4)2
Avg EPS beat(4)-16.75%
Min EPS beat(4)-91.07%
Max EPS beat(4)63.2%
EPS beat(8)5
Avg EPS beat(8)2.53%
EPS beat(12)5
Avg EPS beat(12)-793.15%
EPS beat(16)6
Avg EPS beat(16)-758.16%
Revenue beat(2)0
Avg Revenue beat(2)-5.7%
Min Revenue beat(2)-8.71%
Max Revenue beat(2)-2.69%
Revenue beat(4)0
Avg Revenue beat(4)-4.79%
Min Revenue beat(4)-8.71%
Max Revenue beat(4)-2.69%
Revenue beat(8)2
Avg Revenue beat(8)-2.15%
Revenue beat(12)2
Avg Revenue beat(12)-3.63%
Revenue beat(16)2
Avg Revenue beat(16)-5.09%
PT rev (1m)4.01%
PT rev (3m)22.19%
EPS NQ rev (1m)-61.59%
EPS NQ rev (3m)-126.26%
EPS NY rev (1m)-10.68%
EPS NY rev (3m)3.38%
Revenue NQ rev (1m)8.96%
Revenue NQ rev (3m)6.82%
Revenue NY rev (1m)1.13%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 61.5
P/S 2.48
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-17.06
EYN/A
EPS(NY)3.21
Fwd EY1.63%
FCF(TTM)-14.63
FCFYN/A
OCF(TTM)-11.85
OCFYN/A
SpS79.64
BVpS-3.81
TBVpS-15.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.45%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 130.38%
Cap/Sales 3.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.37
Altman-Z 1.19
F-Score3
WACC9.36%
ROIC/WACCN/A
Cap/Depr(3y)90.02%
Cap/Depr(5y)74.76%
Cap/Sales(3y)2.43%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-247.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.64%
EPS Next Y91.1%
EPS Next 2Y47.72%
EPS Next 3Y32.64%
EPS Next 5Y20.17%
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%17.67%
Revenue Next Year25.38%
Revenue Next 2Y20.52%
Revenue Next 3Y17.13%
Revenue Next 5Y14.3%
EBIT growth 1Y-1098.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year149.79%
EBIT Next 3Y49.92%
EBIT Next 5Y32.37%
FCF growth 1Y-351.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-261.22%
OCF growth 3YN/A
OCF growth 5YN/A